NCT00472433View on ClinicalTrials.gov

The Efficacy and Safety of Alemtuzumab in Auotoimmune Cytopenias

PHASE2TerminatedINTERVENTIONAL

Enrollment

30

Participants

Timeline

Start Date

March 31, 2007

Primary Completion Date

May 31, 2009

Study Completion Date

May 31, 2009

Conditions

Autoimmune Cytopenias

Interventions

DRUG

Alemtuzumab

Trial Locations (1)

10400

Phramongkutklao Hospital, Bangkok

Sponsors

Collaborators (1)

All Listed Sponsors

collaborator

Bayer

INDUSTRY

lead

Phramongkutklao College of Medicine and Hospital

OTHER